Itraconazole and congestive heart failure. (Regulatory and safety matters).

United States of America -- The manufacturer of itraconazole capsules, injection and oral solution has revised the labelling as a result of ongoing research, monitoring and evaluation of these products. Itraconazole capsules should not be administered to patients with evidence of ventricular dysfunction or a history of congestive heart failure. Rare cases of congestive heart failure and pulmonary oedema have been reported during postmarketing surveillance. If signs or symptoms of congestive heart failure occur during administration of itraconazole …